Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Low-thermal Argon Plasma Devitalization (LtAPD) for the Treatment of Cervical Intraepithelial Neoplasia (CIN) Grade 2 Versus Standard of Active Surveillance

NCT07730645 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT07730645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07730645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Low-thermal Argon Plasma Devitalization (LtAPD) for the Treatment of Cervical Intraepithelial Neoplasia (CIN) Grade 2 Versus Standard of Active Surveillance
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Recruiting
Start date
September 24, 2026
Completion date
September 30, 2029
Enrollment
264 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia grade 2, cervical intraepithelial neoplasia grade 2 (cin2), cin2